Popular Articles
Teeth Whitening Products

Dose Measurement During Prostate Cancer Treatment
A new PTB measuring system offers the possibility of measuring the absorbed dose in the direct environment of the irradiated tumour
generic viagra online
First Evidence That Weed Killers Improve Nutritional Value Of A Key Food Crop
"Increase in Nutritionally Important Sweet Corn Kernel Carotenoids following Mesotrione and Atrazine Applications"
News of the day
Celleron Therapeutics And Astrazeneca Announce Personalised Medicine Collaboration In Cancer For The Development Of AZ's Leading HDAC Inhibitor
Celleron Therapeutics Ltd, the Oxford UK based specialist in the development of individually targeted cancer medicines, has secured exclusive rights to AstraZeneca plc"s lead histone deacetylase (HDAC) inhibitor (AZD 9468), for global development in conjunction with its proprietary "CancerNav" predictive biomarker platform. "CancerNav" specifically identifies those tumours which are most likely to respond to an individual cancer drug, thereby enabling a highly focussed clinical development and commercialisation programme, based on a closely linked diagnostic and therapeutic "personalised medicine" approach.
Health Insurance

Alabama Dept. of Public Health Proposes Civil Penalty Against Company For Failing To Properly Maintain Security, Accountability Of Radioactive s

The Alabama Department of Public Health has proposed a $650 civil penalty against BFGoodrich Tire Manufacturing of Tuscaloosa for a violation of the Rules of the State Board of Health. The department identified the violation when BFGoodrich reported in May that two devices containing radioactive s were missing from the Tuscaloosa plant site. BFGoodrich reported that these devices were last accounted for in October 2008 and were discovered missing on April 22, 2009. The devices have not been located or recovered and may have left the plant site when the production line on which they were attached was dismantled and removed as scrap. Each contained small amounts of the isotope Americium 241. The violation involved the failure of BFGoodrich to properly maintain security and accountability of radioactive s. Such devices are used in fixed gauges that measure the thickness of rubber product during production. "We expect all companies that hold Alabama Radioactive Material licenses to maintain control and accountability of all nuclear material by adhering to the rules," said Kirksey E. Whatley, director of the Office of Radiation Control. "This violation is a concern because someone could have been exposed to radiation if the devices were found and mishandled. There is also the possibility that the devices could be melted as scrap and thus cause radioactive contamination at the steel mill and in recycled steel produced by the mill." Following the discovery of the missing devices, BFGoodrich took immediate corrective actions to properly account for all remaining radioactive devices on site, to retrain employees in the importance of maintaining security and accountability of devices, and to institute revised safety procedures for s of radiation. BFGoodrich Tire Manufacturing has until July 31 to pay or contest the proposed civil penalty. If the proposed civil penalty is contested, and subsequently imposed by the Alabama Department of Public Health, the company may request a hearing. For additional information on the regulation of devices containing radioactive material, please call the Office of Radiation Control, Alabama Department of Public Health, at 1-800-582-1866 or visit http://www.adph.org/radiation. Alabama Department of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):